Lessons from the Development of a Canadian National System of Surveillance

Similar documents
CDRAKE - April 11, 2013 Celina Rayonne Chavannes Director, Research Initiatives, NHCC Project Manager, NPHSNC

Understanding the Epidemiology of Neurological Conditions and Building the Methodological Foundation for Surveillance

NATIONAL SURVEILLANCE OF OSTEOARTHRITIS AND RHEUMTOID ARTHRITIS IN CANADA

Epidemiological Update on Dementia, Including Alzheimer s Disease, in Manitoba:

DIABETES MORTALITY IN NOVA SCOTIA FROM 1998 TO 2005: A DESCRIPTIVE ANALYSIS USING BOTH UNDERLYING AND MULTIPLE CAUSES OF DEATH

What is a Defendable Estimate of 0 Dementia Prevalence and Monetary Costs?

Economic Burden of Musculoskeletal Diseases in Canada

Diabetes and Hypertension in Canada: New data from the Canadian Chronic Disease Surveillance System

Neurological Diseases, Disorders and Injuries in Canada: Highlights of a National Study

Diabetes in Manitoba: Trends among Adults

Life with Arthritis in Canada: A Personal and Public Health Challenge

Chronic Disease Summary: Nunavut (Fiscal Years )

DEMENTIA IN CANADA, INCLUDING ALZHEIMER S DISEASE

Health Links Target Population Ministry of Health and Long-Term Care

Karen Tu MD, MSc, CCFP, FCFP Scientist ICES Associate Professor DFCM, University of Toronto Active Staff Toronto Western Hospital FHT

This page is for information. Do not submit.

HEALTH SYSTEM MATRIX VERSION 8.0 DATA DICTIONARY

Health Aging Data Inventory Project

Strategic Operational Research Plan February 13, Scientific Office Digestive Health Strategic Clinical Network

Following the health of half a million participants

Research Strategic Plan

Index SLEEP MEDICINE CLINICS. Note: Page numbers of article titles are in boldface type.

CHAPTER 4: Population-level interventions

UNIVERSITY OF CALGARY. Development and Validation of an ICD-10 Case Definition for Pediatric Traumatic Brain Injury

American Board of Physical Medicine & Rehabilitation. Part I Curriculum & Weights

Neurological Alliance of Ireland Pre-Budget Submission 2018

Surgical Outcomes: A synopsis & commentary on the Cardiac Care Quality Indicators Report. May 2018

Questionnaire 1 of 5: Cannabis Plant and Cannabis Resin. Introduction

Data Then and Now. What do your Numbers Mean?

Measuring Long-Term Conditions in Scotland - A summary report

Epilepsy Across the Spectrum Promoting Health and Understanding

WHOLE HEALTH: CHANGE THE CONVERSATION. Biofeedback Clinical Tool

PARKINSON S DISEASE MORTALITY IN NOVA SCOTIA FROM 1998 TO 2005: A DESCRIPTIVE ANALYSIS USING BOTH UNDERLYING AND MULTIPLE CAUSES OF DEATH

Introduction to the POWER Study Chapter 1

Measuring and Mapping the Rheumatology Workforce in Canada An update for: Royal College- National Speciality Societies Human Resource for Health

Reviewing Implementation Issues in Dialysis: Challenges and Opportunities. EFTYHIA HELIS, MSc KNOWLEDGE MOBILIZATION

Incidence trends of type 2 diabetes, medication-induced diabetes, and monogenic diabetes in Canadian children

MEMBERSHIP OVERVIEW. To become a member at Warmland, you must provide documentation confirming you fall into at least one of the following categories:

Achievements

POLITICS, SCIENCE, AND EVIDENCE: THE ROLE OF SOCIAL MEDIA IN SHAPING SCIENCE POLICY IN THE CCSVI/LIBERATION THERAPY DEBATE

Michelle Greiver Simone Dahrouge Patricia O Brien Donna Manca Marie-Thérèse Lussier

This questionnaire will ask you about approved medical use of extracts and tinctures of cannabis at national level.

A1. Does your government have a formal, written diabetes policy or strategy?

Aussi disponible en français sous le titre : Le Diabète au Canada : Rapport du Système national de surveillance du diabète, 2009

Report from the National Diabetes Surveillance System:

START HERE, START NOW: CROSS-SECTORAL PARTNERSHIP IN IMPROVING DEPRESSION MANAGEMENT IN PRIMARY CARE

ASBMR. Institute of Musculoskeletal Health and Arthritis (IMHA) Dr. Hani El-Gabalawy Scientific Director Canadian Institutes of Health Research

CTFPHC Working Group Members:

The prevalence of type 2 diabetes mellitus is increasing CMAJ OPEN. Research

Presentation to the Standing Committee on Health Chronic Diseases Related to Aging. October 17, 2011

Canadian Cancer Treatment Linkage Project

Administrative Data: A Valuable Tool for Modeling Health Service Utilization and Outcomes for Chronic Disease

Patient Preference for Outcomes in Critical Care Studies

Pandemic Influenza Planning Considerations in On-reserve First Nations Communities

CONGESTIVE HEART FAILURE DISEASE MORTALITY IN NOVA SCOTIA FROM 1998 TO 2005: A DESCRIPTIVE ANALYSIS USING BOTH UNDERLYING AND MULTIPLE CAUSES OF DEATH

INTER-AMERICAN DRUG ABUSE CONTROL COMMISSION C I C A D

Influenza Vaccination Coverage in British Columbia Canadian Community Health Survey 2011 & 2012

Pre-Budget Submission to the Government of Ontario. Submitted February 2018

THE CANADA-ISRAEL TRANS-ATLANTIC COLLABORATION FOR BRAIN STUDIES

Robin Feldman, MBA & Joy Esterlitz, MS NINDS CDE Team The Emmes Corporation Rockville, MD USA. Thursday, September 14, 2017

The Federal Initiative To Address HIV/AIDS in Canada. Canada s Domestic Response to HIV/AIDS

REPORT FROM THE CANADIAN CHRONIC DISEASE SURVEILLANCE SYSTEM:

Ministry of Health and Long-Term Care. Palliative Care. Follow-Up on VFM Section 3.08, 2014 Annual Report RECOMMENDATION STATUS OVERVIEW

The Academy Capitol Forum: Meet the Experts. Diagnosing Which Health Treatments Improve Outcomes: A PCORI Overview and How to Get Involved

CIHI Trends in Health Inequalities in Canada. APHEO September 15, 2014

MUSCULOSKELETAL AND NEUROLOGICAL DISORDERS

NATIONAL SYNERGISTIC CORE RESOURCES. Kidney REsearch Scientist Core Education and National Training program (KRESCENT)

Lessons learned and strategies for maintaining measles elimination Alberta s perspective

Research CP Overview Webinar #1

Research Initiatives and Future Plans

Neurology: Stroke. Former President Reagan. Evaluation of an Infant s Seizures. Traumatic Brain Injury (TBI) 1/13/2014

New York. Prescribing and Dispensing Profile. Research current through November 2015.

Manitoba Influenza Surveillance Report

Diabetes in Manitoba 1989 to 2006 R E P O R T O F D I A B E T E S S U R V E I L L A N C E

Coalitions Linking Action & Science for Prevention (CLASP)

Addressing Gaps in MS Care. November 6, :00 AM - Noon

Epilepsy Action Day at Queen s Park. December 1, 2014

Nutrition and Physical Activity Situational Analysis

Understanding Medical Assessment and Diagnosis of Concussion in Canada

SALTY Improving End of Life Care in Long Term Care Janice Keefe Scientific Lead and Co Lead Stream 4

2014 Physician Quality Reporting System (PQRS) Measure Applicability-Validation (MAV) Process for Claims-Based Reporting Release Notes

Framework and Action Plan for Autism Spectrum Disorders Services in Saskatchewan. Fall 2008

Information Management. A System We Can Count On. Chronic Conditions. in the Central East LHIN

Canadian Seniors: Polypharmacy and Management in Primary Health Care Settings

Implementing Rapid Response Teams (RRT) National Call September 13, 2007

AHA Clinical Science Special Report: November 10, 2015

OUTLINE AAHPM & HPNA Annual Assembly DISCLOSURE. Dr. Hagen has no conflict of interest to report. Shaping public policy and enhancing care

Vaccine Safety Datalink (VSD)

Canadian Health Care Systems

International Forum on HIV and Rehabilitation Research

An exploration of regional variations across a set of potential quality indicators for seriously-ill home care clients in Ontario

SASKATCHEWAN S HIV STRATEGY UPDATE

The pages that follow contain information critical to protecting the health of your patients and the citizens of Colorado.

Ohio s Medical Marijuana Control Program

Towards a Provincial Strategy

Lauren Griffith McMaster University

A profile of young Albertans with Fetal Alcohol Spectrum Disorder

Health History Questionnaire

JEFFERSON COLLEGE COURSE SYLLABUS OTA105 HEALTH CONDITIONS. 2 Credit Hours

Do Clinical Practice Guidelines Improve Outcomes?

Transcription:

Lessons from the Development of a Canadian National System of Surveillance NATHALIE JETTÉ MD, MSc, FRCPC Assistant Professor Neurology Hotchkiss Brain Institute Calgary Institute of Population and Public Health University of Calgary, Canada Institute of Medicine Workshop on Public Health Surveillance, Population Health Research and Data Collection for the Epilepsies March 21, 2011

Outline of Presentation Chronic Disease Surveillance in Canada (context) National Diabetes Surveillance System (NDSS) Canadian Chronic Disease Surveillance System (CCDSS) National Population Health Study of Neurological Conditions Planning epilepsy surveillance in Canada Lessons learned Administrative health data National health surveys Electronic medical records interrai Canadian Longitudinal Study of Aging

Canadian Chronic Disease Surveillance System

Canadian Chronic Disease Surveillance not an overnight process Year Initiative/Progress 1991 Feasibility of administrative data for diabetes surveillance 1 1996 Diabetes surveillance system in Manitoba 2 1999/2000 Canadian Diabetes Strategy 2003 First report from the National Diabetes Surveillance System (NDSS) 2004 Public Health Agency of Canada forms 2005 Integrated Strategy on Healthy Living and Chronic Disease - Hypertension surveillance feasibility work begins 2006/07 Feasibility studies in 5 provinces for arthritis, asthma, COPD and mental illness 2007/2008 Funding for validation studies (heart disease, stroke, osteoporosis and neurological diseases) 2009/2010 Hypertension added to Canadian Chronic Disease Surveillance System (CCDSS) ~2011/2012 Stroke, ischemic heart disease, myocardial infarction, heart failure to be added to CCDSS ~2012/2013 Arthritis, bowel disease, renal disease and neurological diseases to be added to CCDSS* 1 K. Young et al. CMAJ 1991; 144(3):318-24. 2 J. Blanchard et al. Diabetes Care 1996;19:807-11. *Neurological Disease Surveillance Advisory Committee (formed Dec 2009) and CCDSS Neurological Diseases Working Group (formed Jan 2011)

NDSS Report Sample Data (Prevalence) Similar data are generated on incidence, multi-morbidity, health services utilization and mortality

National Population Health Study of Neurological Conditions (NPSNC)

National Population Health Study of Neurological Conditions (NPSNC) Purpose of Study (2010-2013): To develop a better understanding of the epidemiology and impact of 14 neurological conditions * by addressing the following areas: 1. Incidence, prevalence 2. Multi-morbidities 3. Impact to individuals, families and societies 4. Health systems services 5. Risk factors for the development of conditions and poor health outcomes *Alzheimer s disease and related dementia, amyotrophic lateral sclerosis, brain tumours, cerebral palsy, dystonia, epilepsy, Huntington s disease, hydrocephalus, multiple sclerosis, muscular dystrophy, Parkinson s disease, Tourette Syndrome, traumatic brain injury, spina bifida, spinal cord injury

National Population Health Study of Neurological Conditions The NPSNC Integrated Knowledge Translation from A to Z Federal Government Agencies Ministry of Health, Statistics Canada Public Health Agency of Canada (PHAC) Canadian Institutes for Health Research (CIHR) Canadian Institute of Health Information (CIHI) Neurological Health Charities of Canada (NHCC) Established 2006 Responsible for obtaining funding for NPSNC from government by lobbying Now consists of > 25 neurological charities Researchers Clinicians Researchers Research Associates Students Other Stakeholders Provincial health ministry managers (Alberta Health and Wellness, etc) Patients Miscellaneous other stakeholders

National Population Study of Neurological Conditions example of data sources Incidence Prevalence Comorbidity Administrative data Canadian Community Health Survey (CCHS) Canadian Primary Care System Surveillance Network (CPCSSN) Clinical Registries interrai Impact of Neurological Conditions Follow up impact survey to CCHS Experience of people with neurological conditions, their families and caregivers (Aboriginal survey, national survey) interrai Health Systems Services Administrative data Canadian Community Health Survey Canadian Primary Care System Surveillance Network interrai Other data sources through funded projects

Planning Epilepsy Surveillance in Canada

Data Source Target Population Advantages & Disadvantages Administrative Data (e.g. CCDSS) Hospitalizations Physician visits National Health Surveys e.g. Canadian Community Health Survey Electronic Medical Records Canadian Primary Care Sentinel Surveillance System Network (CPCSSN) interrai Everyone in Canada who seeks medical care Age 12 and older * Some exclusions 130,000 every 2 years Canadian Longitudinal Study of Aging Ages 45-85 50,000 All age groups Patients seen in primary care >200,000 currently Up to 1 million by 2015 Patients in complex continuing care facilities, nursing homes, mental health institutions, those receiving home care services Population-based, cost effective Can follow patients longitudinally Can link to other data sources (labs, drug data) Population-based Costly Cross sectional (prevalence only) Self report Population based in some areas Can follow patients longitudinally Includes medications, lab data Clinical diagnoses # of EMR vendors high Population-based in some provinces Rich clinical data (not admin data) Clinical diagnoses Validated scales Population based (excl. territories) Costly but rich longitudinal data Full clinical assessments in 30,000 Long follow up (20 years +) *for 2010-2012 CCHS< neurological conditions are being captured for every household members exclusions: population on Indian Reserves, living in remote areas, living in long term care institutions, Canadian Force Bases.

Administrative Health Data First step is validating condition of interest, then develop best case definition algorithm Lessons Learned in Canada: Easy to validate hospitalization and emergency room visit data data are very good *, accessible, affordable, etc. Tougher to validate epilepsy coding in primary care if a large portion of epilepsy care is provided by general practitioners, need to validate epilepsy coding from that source More challenging to validate GP coding Need to collaborate with physicians who are part of a primary care network, national surveillance system, etc to increase likelihood of success. Can be used as a sampling frame for more in-depth studies *Jetté et al. Epilepsia 2010

National Health Surveys CCHS cross sectional but q2 years (130,000 people) ~80% response rate Do provide rich health related data including data on comorbidities, health related behavior, access to care, etc. Lessons Learned in Canada If based on self report of epilepsy, important to ask respondents if they have epilepsy or if they have a seizure disorder Can be used as sampling frame but very costly E.g. follow-up impact survey currently underway for every CCHS respondent who answered yes to having a neurological condition

Electronic Medical Records - CPCSSN Network of sentinel family physicians attached to primary care research networks across Canada which collects data from their electronic medical records at regular intervals to develop a longitudinal database for the purposes of epidemiological surveillance and research. Initial focus: COPD, diabetes, hypertension, osteoarthritis and depression New focus: epilepsy, Parkinson s disease, and dementia data on prevalence, incidence, multi-morbidities, risk factors, medications, health services, procedures, etc

Electronic Medical Records - CPCSSN Lessons Learned in Canada: Critical to ensure primary care physicians are engaged, and see this as value-add Physicians appreciate getting reports back on their patient population Performance measurement o What % of their patients with diabetes have HbA1C in the target range? o What % of their patients with hypertension have adequate blood pressure measurements? It is possible to do this with a variety of EMR vendors. Primary care physicians are very interested in this initiative.

interrai Enables care providers to assess the following factors in patients who are receiving home care, who are living in institutions etc: Function, health, social support, service use, quality of life Data complete in settings where it is being collected Lessons Learned: Important to validate diagnosis * Mandated in some provinces, not in others thus not consistently collected best in provinces where mandated Assessments done annually (always done) and quarterly if changes in clinical status (not always done) Important to fill gaps around transition of care by linking to other data sources (e.g. hospitalization data) *Hardie et al. Epilepsy Res 2007 The validity of epilepsy or seizure documentation in nursing homes (>92% agreement between neurologists review of nursing home records and minimum data set documentation).

Canadian Longitudinal Study of Aging Enrolling 50,000 Canadians ages 45-85 Plan for 20+ years follow up Extensive clinical, biological, physical data being collected on 30,000 (in-depth assessments) Questionnaires and database linkages planned for all 50,000 over 20+ years Lessons learned: Very costly Challenging to link to other data sources nationally But an excellent and rich source of clinical, biological and physical data

Recommendations 1. Build on existing infrastructure and methodology to increase likelihood of feasibility. Collaborate with individuals involved in other surveillance systems (e.g. ongoing CDC surveillance initiatives) 2. Several data sources may be necessary to address complete population Administrative data to capture all those who access medical services National health surveys will also capture those who may not currently be seeking medical care interrai data will capture those in nursing homes, those receiving home care, etc.

Recommendations 3. Consider using administrative data as sampling frames for surveys Although administrative data may not address epilepsy severity or impact on QOL, consider using them as sampling frames for more detailed surveys. 4. Consider electronic medical records for surveillance Feasible, cost effective once in place, as long as participating sentinel physicians are engaged and see it as value added